- Home
- EXEL vs FHN Comparison
EXEL vs FHN Comparison
Compare EXEL & FHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- FHN
- Stock Information
- Founded
- EXEL 1994
- FHN 1864
- Country
- EXEL United States
- FHN United States
- Employees
- EXEL N/A
- FHN N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- FHN Major Banks
- Sector
- EXEL Health Care
- FHN Finance
- Exchange
- EXEL Nasdaq
- FHN Nasdaq
- Market Cap
- EXEL 10.4B
- FHN 11.0B
- IPO Year
- EXEL 2000
- FHN N/A
- Fundamental
- Price
- EXEL $37.88
- FHN $22.26
- Analyst Decision
- EXEL Buy
- FHN Buy
- Analyst Count
- EXEL 21
- FHN 17
- Target Price
- EXEL $43.65
- FHN $23.32
- AVG Volume (30 Days)
- EXEL 2.4M
- FHN 10.4M
- Earning Date
- EXEL 10-28-2025
- FHN 10-15-2025
- Dividend Yield
- EXEL N/A
- FHN 2.70%
- EPS Growth
- EXEL 81.76
- FHN 28.04
- EPS
- EXEL 2.08
- FHN 1.55
- Revenue
- EXEL $2,230,005,000.00
- FHN $3,083,000,000.00
- Revenue This Year
- EXEL $9.24
- FHN $10.95
- Revenue Next Year
- EXEL $13.04
- FHN $3.68
- P/E Ratio
- EXEL $18.24
- FHN $14.37
- Revenue Growth
- EXEL 10.73
- FHN 4.62
- 52 Week Low
- EXEL $25.12
- FHN $14.83
- 52 Week High
- EXEL $49.62
- FHN $23.00
- Technical
- Relative Strength Index (RSI)
- EXEL 44.99
- FHN 51.21
- Support Level
- EXEL $36.23
- FHN $22.08
- Resistance Level
- EXEL $38.95
- FHN $22.98
- Average True Range (ATR)
- EXEL 0.85
- FHN 0.44
- MACD
- EXEL 0.13
- FHN -0.00
- Stochastic Oscillator
- EXEL 60.66
- FHN 51.67
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About FHN First Horizon Corporation
First Horizon Corp is the parent company of First Tennessee Bank, a prominent regional bank with about 200 branches around Tennessee. The company's reportable segments are: Commercial, Consumer & Wealth, Wholesale, and Corporate. The majority of its revenue is generated from Commercial, Consumer & Wealth. The Commercial, Consumer & Wealth segment offers financial products and services, including traditional lending and deposit taking, to commercial and consumer clients in the southern USA and other selected markets.